Electroconvulsions were evoked by an electric stimulus (an alternating current 25 mA, 50 Hz,500 V, 0.2 s) generated by a rodent shocker (Hugo Sachs Elektronik, Freiburg, Germany) and delivered via ear-clip electrodes. Tonic hindlimb extension (i.e., hindlimbs of animals outstretched 180 to plane of the body axis) was established as the endpoint. ED50 is a median effective dose of the tested drug that protects 50% of mice against maximal electroshock-induced seizures. A dose–response curve was calculated on the basis of the percentage of mice protected according to Litchfield and Wilcoxon [60]. This experimental procedure has been described in detail in our previous studies [12,13,14].
C-11 was administered in doses that, per se, had no effect on seizure threshold in the maximal electroshock seizure threshold test. C-11 doses were selected based on previous studies where C-11 administered at a dose below 50 mg/kg protected mice from tonic hind limb extension after stimulation in MES test [15]. In addition, for ethical reasons, in accordance with the 3Rs rule, the maximal electroshock seizure threshold test (which would require at least additional 128 mice) was not performed.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.